Ledger.Open graph →
SEC Form D · filed April 3, 2009

Nitric BioTherapeutics, Inc

Offering
$2.2M
Sold
$1.7M
Exemption
—
Industry
Biotechnology
Location
BRISTOL, PA
Type
—

People & firms on this filing (9)

Matthew Rieke · Bristol, PADirectorZev M. Scherl · Bristol, PADirectorFrank J. Mccaney · Bristol, PAExec · DirectorWilliam F. Souder · Chicago, ILExec · DirectorJacob L. Slevin · New York, NYDirectorAvichai Flombaum · New York, NYDirectorRichard Caruso · Bristol, PADirectorHarold Chefitz · Bristol, PADirectorHugh Macnaught · Bristol, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗